El Al Airlines orders two 777s

By
December 13, 2005 19:33

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Israel's El Al Airlines has finalized a purchase agreement with The Boeing Co. for two extended-range 777 jetliners, the companies said Tuesday. The deal was worth $362 million (€303.5 million) at list prices, but airlines typically negotiate discounts. Chicago-based Boeing is scheduled to deliver the two 777-200ERs in 2007. El Al said the planes will help it expand service to meet a growing demand for air travel in the Israeli market. "We are delighted that El Al continues to choose the 777 as the most efficient airplane to meet increased demand for long-haul service," Scott Carson, vice president of sales for Boeing's commercial airplane division, said in a statement. El Al already has four 777s on routes to New York and the Far East from Tel Aviv. It will fly the new 777s to destinations in the United States and the Far East.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS